169 related articles for article (PubMed ID: 6719194)
1. [Comparative evaluation of the efficacy of complex anti-ulcer therapy and monotherapy].
Grigor'ev PIa; Khar'kovskiĭ NN; Elina NA; Iakovenko EP
Sov Med; 1984; (2):100-1. PubMed ID: 6719194
[No Abstract] [Full Text] [Related]
2. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
[No Abstract] [Full Text] [Related]
3. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
4. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
5. Triple therapy and Helicobacter pylori.
Davis S
Aust Fam Physician; 1996 Jan; 25(1):53, 56-9. PubMed ID: 8607776
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
Bayerdörffer E; Mannes GA; Pfaller P; Sauerbruch T
Internist (Berl); 1989 Jun; 30(6):390-2. PubMed ID: 2668217
[No Abstract] [Full Text] [Related]
7. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
8. [High demands on drug administration and pharmacological principles applied in ulcer diseases].
Hellström PM
Lakartidningen; 1991 Feb; 88(6):425-30. PubMed ID: 1671887
[No Abstract] [Full Text] [Related]
9. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
Chearanai O; Kachintorn U; Plengvanit U
J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
[No Abstract] [Full Text] [Related]
10. [Tripotassium dicitrato bismuthate in the therapy of peptic ulcer: comparison with ranitidine in short-term treatment].
Capurso L; Tarquini M; Luzietti L; Palomba M; Bazuro G; Papi C; Fracasso P; Koch M
Clin Ter; 1984 May; 109(4):335-44. PubMed ID: 6088161
[No Abstract] [Full Text] [Related]
11. [Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease].
Maev IV; Samsonov AA; Golubev NN
Klin Med (Mosk); 2008; 86(9):57-63. PubMed ID: 19048841
[TBL] [Abstract][Full Text] [Related]
12. [A comparative evaluation of the efficacy of the monotherapy of peptic ulcer using EHF-puncture and basic drug therapy].
Razumov AN; Voznesenskaia OA
Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (5):10-1. PubMed ID: 10598520
[TBL] [Abstract][Full Text] [Related]
13. [Famotidine treatment of patients with gastric and duodenal ulcers. A comparative study with once or twice-a-day administration].
Bonardelli P; Fujita Y; Fujita R; Sugata F
Clin Ter; 1987 Aug; 122(3):183-7. PubMed ID: 2904317
[No Abstract] [Full Text] [Related]
14. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori].
González Carro P; Legaz Huidobro ML; Pérez Roldán F; Ruíz Carrillo F; Pedraza Martín C; Sáez Bravo JM
Rev Esp Enferm Dig; 1998 Aug; 90(8):594-5. PubMed ID: 9780793
[No Abstract] [Full Text] [Related]
16. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
Pal'tsev AI; Maslennikova TA
Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
[No Abstract] [Full Text] [Related]
17. [Comparative evaluation of the efficacy of monotherapy with cimetidine and combined treatment of the recurrent duodenal ulcer].
Grigor'ev PIa; Khar'kovskiĭ NN; El'tsova GB; Prianishnikova AS; Iakovenko EP
Ter Arkh; 1983; 55(9):107-10. PubMed ID: 6635966
[No Abstract] [Full Text] [Related]
18. [Effectiveness of eradication anti-helicobacter therapy in patients with duodenal ulcer in different drug dosage regimens].
Orziev ZM; Nurbaev FE; Rakhimova GSh
Klin Med (Mosk); 2003; 81(6):48-9. PubMed ID: 12875192
[TBL] [Abstract][Full Text] [Related]
19. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
